What is the appropriate management of a patient with end‑stage renal disease who is not in diabetic ketoacidosis but has positive ketones?

Management of Positive Ketones in ESRD Patients Without DKA

In ESRD patients with positive ketones but no DKA, focus on identifying the underlying cause (starvation ketosis, SGLT2 inhibitor use, or uremia-related ketosis) and provide supportive care with carbohydrate intake and close monitoring—do not treat with standard DKA protocols unless true DKA develops.

Initial Assessment and Differentiation

The critical first step is distinguishing between benign ketosis and evolving DKA. Check:

• Blood glucose level (euglycemic vs hyperglycemic ketosis)
• Arterial pH and bicarbonate (to confirm absence of significant acidosis)
• Beta-hydroxybutyrate level if available (quantitative assessment)
• Medication history, specifically SGLT2 inhibitor use
• Recent oral intake (prolonged fasting or poor nutrition)

ESRD patients can develop ketosis without DKA due to several mechanisms: starvation from poor appetite, uremia-induced nausea reducing carbohydrate intake, or SGLT2 inhibitor use if prescribed before reaching ESRD 1.

Management Algorithm

If Ketones Present Without Acidosis (pH >7.30, bicarbonate >15):

1. Identify and address the precipitant:

• If starvation ketosis: Provide oral or IV dextrose-containing fluids and encourage carbohydrate intake
• If SGLT2 inhibitor-related: Discontinue the SGLT2 inhibitor immediately, as these agents should be stopped when dialysis is initiated 2, 3
• If illness or reduced intake: Address the underlying condition and restore nutrition

2. Fluid management (cautious in ESRD):

• Avoid aggressive fluid resuscitation that would be used in DKA
• ESRD patients are typically volume-sensitive and at high risk for pulmonary edema 4
• Consider small volumes of dextrose-containing fluids (D5W or D10W) to suppress ketogenesis
• Coordinate with nephrology regarding dialysis timing

3. Monitor for progression:

• Serial glucose, electrolytes, and venous pH every 2-4 hours initially
• Watch for development of true DKA (pH <7.30, anion gap acidosis)
• Monitor potassium closely as it can shift unpredictably

If True DKA Develops (pH <7.30 with ketones and hyperglycemia):

Modified DKA management for ESRD patients:

• Insulin: Use reduced rates (0.05 units/kg/hr rather than standard 0.1 units/kg/hr) due to impaired renal clearance 4, 1
• Fluids: Severely restrict compared to standard DKA protocols—typically 50-100 mL/hr maximum to avoid volume overload 4
• Potassium: Exercise extreme caution with replacement; ESRD patients cannot excrete excess potassium 1
• Consider urgent dialysis for severe refractory acidosis (pH <7.0), hyperkalemia, or volume overload 4, 5, 6

Critical Pitfalls to Avoid

Volume overload is the most dangerous complication when managing any metabolic derangement in ESRD patients. Standard DKA fluid protocols (1-2 liters bolus followed by 250-500 mL/hr) will cause pulmonary edema and potentially death in anuric patients 4, 7.

Do not give potassium supplementation reflexively. Unlike non-ESRD DKA patients who universally need potassium, ESRD patients may already be hyperkalemic or become so rapidly with insulin cessation 1.

Recognize euglycemic ketoacidosis if the patient was on an SGLT2 inhibitor. Blood glucose may be normal or only mildly elevated despite significant ketosis 3, 1. The KDIGO guidelines explicitly state SGLT2 inhibitors should be withheld during critical illness and discontinued when dialysis begins 2.

Role of Dialysis

Emergency hemodialysis serves as rescue therapy when:

• pH remains <7.0 despite conservative measures
• Severe hyperkalemia develops (>6.5 mEq/L with ECG changes)
• Volume overload occurs from necessary fluid administration
• Acidosis is refractory to standard treatment 4, 5, 6

Continuous renal replacement therapy (CRRT) may be preferable to intermittent hemodialysis for gradual correction of severe metabolic derangements, though this requires ICU-level care 5.

Monitoring Parameters

Track these closely during management:

• Glucose every 1-2 hours initially
• Venous pH and electrolytes every 2-4 hours
• Volume status (lung exam, oxygen saturation, weight if available)
• Potassium levels before any insulin administration
• Mental status and neurological exam

When to Escalate Care

Transfer to ICU if:

• pH drops below 7.1
• Altered mental status develops
• Hemodynamic instability occurs
• Urgent dialysis is needed
• Mechanical ventilation is required

The evidence shows ESRD patients with DKA have significantly higher rates of complications including vasopressor requirements, mechanical ventilation, and cardiac arrest compared to non-ESRD patients, though mortality rates are similar 8. This underscores the need for intensive monitoring even when initial presentation seems mild.